1 / 37

History

History. General Data. 33/F G4P2 (2012) R oman C atholic From Quezon City Admitted: August 13, 2009 CC: L breast mass. History of Present Illness. 11 months PTA: ~ 2x2cm breast mass, (L) (+) slight tenderness ( -) accompanying skin changes/nipple discharge/weight loss

topper
Download Presentation

History

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. History

  2. General Data • 33/F • G4P2 (2012) • Roman Catholic • From Quezon City • Admitted: August 13, 2009 • CC: L breast mass

  3. History of Present Illness 11 months PTA: • ~2x2cm breast mass, (L) • (+) slight tenderness • (-) accompanying skin changes/nipple discharge/weight loss • (-) consults done/medications taken

  4. History of Present Illness 8 months PTA: • (+) gradual enlargement of mass • consult at a local hospital • CNB: results showed fibrocystic changes • No medications/interventions • advised observation.

  5. History of Present Illness 1 month PTA: • Mass continued to enlarge; noted to triple in size • (+) nipple retraction • consult at BCC • Slide review of previous CNB slide: invasive ductal CA

  6. History of Present Illness 1 month PTA: • (+) missed menses for 4 weeks • (-) nausea/vomiting • (+) slight dizziness • pregnancy test: positive • (-) consults / medications

  7. Review of Systems • (-) fever • (-) weight loss • (-) rashes • (-) headache/dizziness • (-) nasal discharge • (-) difficulty of breathing / dyspnea • (-) chest pain • (-) urinary complaints • (-) bowel disturbance

  8. Past Medical History • (-) DM / HPN / PTB / allergies / asthma • Nocomorbidities

  9. Family Medical History • (-) CA, breast mass • (-) Hypertension, DM, asthma, thyroid disorder, epilepsy

  10. Menstrual History • Menarche: 12 yrs. Old • interval of 30 days • lasting for 3-5 days • consumes 3 pads per day, fully soaked • (-) dysmenorrhea • LMP: May 23, 2009

  11. Sexual History • Firstcoitus 26 y/o (current partner, nonpromiscuous) • (-)dyspareunia • (-) post coital bleeding • (-) family planning method

  12. Obstetric History

  13. Personal/Social History • housewife • Non-smoker • Non-alcoholic beverage drinker • Denies illicit drug use

  14. Physical Examination

  15. Physical Examination • Conscious, coherent, ambulates with assistance, not in cardiorespiratory distress • Vitals: BP 120/80 HR 82 RR 20 T 36.8

  16. Physical Examination HEENT: • Pink palpebral conjunctivae, anictericsclerae, pupils ERTL • Supple neck, no palpable cervical lymph nodes, Thyroid gland not enlarged

  17. Physical Examination Chest/Lungs: No retractions, Symmetrical chest expansion, clear breath sounds CVS: Adynamicprecordium, AB at 5th LICS MCL, no murmur

  18. Physical Examination Abdomen: Globular, NABS Skin/Extremities: • Warm, moist skin, no active dermatosis • Full and equal pulses, no clubbing or cyanosis of extremities, no edema

  19. Physical Examination Breast • 10x10 cm mass- hard, slightly tender, non movable mass L breast, • (+) nipple retraction • (-) skin changes/nipple discharge • Essentially normal R breast • (-) palpable axillary/cervical nodes

  20. Physical Examination Genitourinary: • Normal external genitalia, no vaginal discharge, no external lesion • Internal Examination: Cervix- soft, long, closed; Uterus- enlarged to approximately 12 weeks, no adnexal mass/tenderness

  21. Physical Examination Neurologic Examination • Awake, alert, oriented to 3 spheres • pupils 2-3 mm ERTL, no visual field cuts, (+) ROR – OU • full and equal EOM’s, V1-3 intact, can clench teeth, Can smile, can raise eyebrows, can close both eyes, no asymmetry, Intact gross hearing, no lateralization on Weber’s, AC > BC on Rinne, tongue midline on protrusion, can raise shoulders

  22. Physical Examination Neurologic Examination • - Motor: (-) spasticity, rigidity, fasciculation, MMT 5/5 on all extremities • ++ DTR’s on all extremities • (-) sensory deficit • (-) Babinski, (-) nuchal rigidity

  23. Course in the Wards

  24. Course in the Wards • 8/13/09 (1st hospital day) • Admitted to W4B29 • 8/14/09 (2nd hospital day) • Referred to OB-GYN

  25. Course in the Wards • 8/15/09 (3rd hospital day) • OB-Gyn: TV-UTZ done, showing early fetal demise; suggest cervical ripening with laminariax 24h then reassessment of cervix. • presented with possibility of D&C after MRM if Sx is amenable

  26. Course in the Wards • 8/16/09 (4th hospital day) • GS1: Noted OB entries • For OR scheduling: MRM, L • NPO • IVF: D5NR 1L x 8h • Cefazolin 1g IV LD ( ) ANST to be given at OR • OB may do D&C or insert laminaria • Anesthesiology: plan – GETA • pre-op meds – nalbuphine 5mg + promethazine 25mg as cocktail

  27. Course in the Wards • 8/16/09 (4th hospital day) • OB-Gyn: will do D&C after MRM • Anesthesiology: plan – GETA • pre-op meds – nalbuphine 5mg + promethazine 25mg as cocktail • IVF: D5NR x 8h + K50 ext tubing on RUE (IV Cannula g18)

  28. Laboratory Examinations

  29. Laboratory Examinations • Blood Type: A+ • CBC Hgb 122, Hct 0.394, WBC 9.78, RBC 4.33, Plt 302, N 0.660, L 0.272 • PT 12.9/12.4/0.98/1.19 • aPTT 36.9/33.0 • BUN 2.68, Crea 50(L), Na 140, K 3.7, Cl 104

  30. Ethical Considerations

  31. Ethical Considerations • 1st Trimester • MRM (procedure of choice), in spite of increased risk spontaneous abortion following anesthesia • Chemotherapy - 12% risk of birth defects and risk for spontaneous abortion • 2nd Trimester • MRM (procedure of choice) • Chemotherapy – no evidence of teratogenicity

  32. Ethical Considerations • 3rdTrimester • Lumpectomy with axillary node dissection if adjuvent radiation therapy if deferred until delivery • Chemotherapy: no evidence of teratogenicity • Prognosis is similar, stage by stage, to that of nonpregnant Breast CA patients

  33. Ethical Considerations • Upon questioning, the patient was willing to undergo chemotherapy and surgery in spite of the risk of spontaneous abortion to the fetus • According to her and her family, it is more important to have her cured • She finds herself unable to continue the pregnancy if she still has cancer

  34. Ethical Considerations • Philippine Constitution Article 2, Sec 12: • The State recognizes the sanctity of family life and shall protect and strengthen the family as a basic autonomous social institution. It shall equally protect the life of the mother and the life of the unborn from conception. The natural and primary right and duty of parents in the rearing of the youth for civic efficiency and the development of moral character shall receive the support of the Government.

  35. Ethical Considerations • Grounds on which abortion is permitted in the Philippines: • To save the life of a woman YES • To preserve physical health NO • To preserve mental health NO • Rape/incest NO • Fetal impairment NO • Economic/social reasons NO • Available on request NO

  36. Ethical Considerations • Authorization of an abortion requires consultation with a panel of professionals

  37. Source • Brunicardi,et. Al. (2005). Schwartz’s Principles of Surgery. 8th Ed. McGraw-Hill, USA. • Philippine Constitution • UN Abortion Policies: A Global Review (2002) http://www.un.org/esa/population/publications/abortion/profiles.htm. accessed on 8/17/09

More Related